H eart failure (HF) is the top discharge diagnosis for the Centers for Medicare & Medicaid Services (CMS) and the leading cause of rehospitalization within 30 days of an index hospitalization. 1 As a result, CMS has recognized the need to curb excessive rehospitalization and mortality rates and has initiated public reporting of risk-adjusted rates for hospitals. In addition, CMS now financially penalizes hospitals with high rehospitalization rates for HF through the Hospital Readmissions Reduction Program, as well as high mortality rates as part of the composite score used in the Hospital Value-Based Purchasing Program. [2] [3] [4] The riskadjustment models currently used by CMS incorporate data exclusively from administrative claims. 5, 6 Previous research indicates that adding clinical data to claims data for HF hospitalizations significantly improves prediction of mortality and shifts mortality performance rankings for a substantial proportion of hospitals. 7 However, incorporating clinical data does not meaningfully improve prediction of rehospitalization and has little effect on performance rankings based on rehospitalization. 7 
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Neither claims nor clinical data account for a patient's socioeconomic status (SES) environment, which can differ in many aspects potentially related to health. [8] [9] [10] The SES context of a community has been shown to be related to health status and mortality, [10] [11] [12] [13] [14] [15] as well as to health-related behaviors, including smoking, dietary habits, and physical activity. [16] [17] [18] [19] [20] The relationship between the characteristics of a community and health outcomes seems to be independent of the SES position of individual people. This has been demonstrated in coronary artery disease studies; after controlling for personal income, education, and occupation, living in a disadvantaged neighborhood is associated with an increased incidence of having coronary artery disease. 21 Differences in hospital-level postdischarge outcomes are partially related to both the SES mix and racial/ethnic backgrounds of the patient population served. 22, 23 Nevertheless, the risk-adjustment models currently used by CMS to determine financial penalties for excess readmissions account for neither. Patient risk factors such as age, sex, and selected clinical covariates are considered, but their SES is not. As a result, hospitals that care for vulnerable populations may be disproportionately penalized for postdischarge outcomes independent of the quality of care delivered. An expert panel convened by the National Quality Forum concluded that a lack of adjustment for SES factors might unintentionally worsen disparities by penalizing the providers that care for disadvantaged populations. 24 The panel acknowledged the lack of high-quality and readily available SES data that could be incorporated into risk adjustment models and recommended that a standard set of SES variables should be identified and collected. Several standard SES variables have been used to establish the relationship between neighborhood of residence and incidence of coronary artery disease, 21 but their relationship to early outcomes in patients with HF is unclear.
Using data from the Get With The Guidelines-Heart Failure (GWTG-HF) Registry linked with the CMS database and county-level census data from Area Health Resource Files, we sought to determine (1) whether county-level SES variables are associated with 30-day outcomes for older patients with HF, (2) whether county-level SES accounts for the association of race with 30-day outcomes, and (3) whether county-level SES data alone, and in concert with, clinical data can improve risk adjustment beyond current CMS models.
Methods

Data Sources
We linked data from GWTG-HF with CMS enrollment files and inpatient claims from January 1, 2005 to December 30, 2011. The design, inclusion criteria, and data collection methods have been previously published. 25 Patients were eligible for inclusion if they were admitted for an episode of worsening HF or developed significant HF symptoms during a hospitalization for which HF was the primary discharge diagnosis. Hospital teams used HF case-ascertainment methods similar to those used by the Joint Commission. Data on demographics (ie, age, sex, race/ethnicity) medical history, signs and symptoms, medications, contraindications for or intolerance to medications, and diagnostic test results were collected in the GWTG-HF database using the Internet-based Patient Management Tool (Quintiles Real-World & Late Phase Research, Cambridge, MA). Race/ethnicity data were collected in GWTG-HF by patient self-reporting as recorded by admissions or medical staff during registration. Race was recorded as part of a multiple-choice data entry tool (ie, white, black, Asian, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander). A separate data element for Hispanic ethnicity (ie, yes versus no/not documented) was also used. All regions of the United States were represented, and a variety of centers participated, from community hospitals to large tertiary centers.
All participating institutions were required to comply with local regulatory and privacy guidelines and, if applicable, to obtain institutional review board approval. Because the data were primarily used at the local site for quality improvement, sites were granted a waiver of informed consent under the Common Rule. The Duke Clinical Research Institute (Durham, NC) served as the data analysis center. The CMS files included data on all fee-for-service CMS beneficiaries aged ≥65 years hospitalized with a diagnosis of HF (International Classification of Diseases-Ninth Revision, Clinical Modification codes 428.x, 402.x1, 404.x1, and 404.x3). We linked patient data in the registry with CMS Part A inpatient claims, matching by admission and discharge dates, hospital, date of birth, and sex. 26 We then linked these clinical data to county-level SES data using Population Characteristics and Economic Data in the 2012 Area Health Resources Files. To link the clinical and SES data, we used the Federal Information Processing Standard county code associated with the patient's zip code from the index claim or the denominator file for the year of the index claim.
End Points and Definitions
Consistent with metrics publicly reported by CMS, 27 the primary end points evaluated in this analysis were mortality within 30 days of admission and all-cause rehospitalization within 30 days of discharge. Similar to other studies of CMS beneficiaries, we obtained dates of death from CMS enrollment files and rehospitalization dates from Part A inpatient claims. Patients who died out of hospital before a rehospitalization were counted as no for the rehospitalization outcome to match the definition in the CMS 30-day rehospitalization measure.
Statistical Analysis
Patient characteristics, including demographics, history and risk factors, and hospital characteristics, were presented by outcomes. Categorical variables were presented as frequencies (percentages) and differences by outcome were assessed using the χ 2 test when the sample size was sufficient; otherwise, an exact test was used. Continuous variables were presented as median (Q1, Q3) and were compared using the Wilcoxon rank-sum test. To assess the association of SES with outcomes, we used a logistic regression model with random-intercepts for site. The random hospital intercept is a shrunken estimator and represents the log odds of the outcome for each hospital. To determine whether SES data improved discriminatory power, we fit a series of models for each outcome. First, we fit a model adjusting for only SES environmental characteristics. Second, we added prespecified patient characteristics. Finally, we added hospital characteristics. C-indexes were used to assess the discriminatory power of the models. We also fit the current/ standard adjustment model based on patient-and hospital-level characteristics. For comparison with current models espoused by CMS, 5, 6 we fit the adjustment models based on patient characteristics alone.
We adjusted for a prespecified list of clinical and hospital characteristics including age, sex, medical history (atrial fibrillation/ flutter, anemia, chronic obstructive pulmonary disease, depression, diabetes mellitus, HF, hypertension, prior implantable cardioverter-defibrillator, ischemic pathogenesis of HF, dyslipidemia, pacemaker, peripheral vascular disease, renal insufficiency, cerebrovascular accident/transient ischemic attack, valvular heart disease, and smoking history), vital signs (systolic blood pressure, heart rate, and respiratory rate), laboratories (sodium, serum creatinine, blood urea nitrogen, and hemoglobin), and year of index hospitalization. Hospital characteristics included in adjustment were region (Midwest, West, South, versus Northeast), number of beds, teaching status (academic or residents), and rural (versus urban). Adapting from the list of variables used by Diez Roux et al 21 . The plots of observed versus predicted outcomes defined by deciles were used to evaluate model performance on calibration. Spearman rank correlation coefficient was used to quantify the association between site event rates (ie, hospital rankings) under different models using the estimated hospital random intercepts. To assess whether race is a placeholder for SES, we fit 2 logistic regression models for each outcome. In the first model, we adjusted only for race. In the second model, we adjusted for race and SES variables. If race was significantly associated with the outcomes before and after adjusting for SES variables, then SES variables would not be considered a placeholder for race.
All statistical tests were 2-sided and we considered α <0.05 to be significant. We used SAS version 9.3 software (SAS Institute, Cary, NC) for all analyses.
Results
Our starting population included 66 090 patients discharged between January 1, 2005 and December 30, 2011 from 292 hospitals fully participating in GWTG-HF with CMS linkage. We obtained a final study population of 48 338 patients from 197 hospitals after excluding patients with different discharge dates in CMS files and registry (n=1058; 0 sites), patients not eligible for fee-for-service CMS at discharge (n=2565; 0 sites), patients who did not have at least 1 admission vital sign (n=4817; 3 sites), patients who did not have at least 1 admission laboratory (n=8321; 11 sites), and patients from hospitals with <25 patients in the study population (n=991; 81 sites). Among the 48 338 patients who had at least 30 days of followup after their index admission, 4391 (9.1%) died within 30 days of admission. Among the 44 217 patients who survived until discharge and were not transferred out, 9107 (20.6%) were readmitted within 30 days of discharge, and 10 515 (23.8%) either died or were readmitted within 30 days of discharge. The median age of the overall cohort was 80 years (25th, 75th: 74, 86), 54.5% were women, and 81.3% were white (Table 1) . Hypertension was the most frequent comorbidity, occurring in 77.2% of patients. The median household income was USD $45 902 (25th, 75th: $40 780, $53 677), which is lower than the United States 2010 to 2012 3-year average of $51 771. 27 In zip codes where patients resided, the median percentage of people with at least a high school diploma was 85.7% (25th, 75th: 82.1, 88.5), and the median percentage of people with at least 4 years of college was 26.1% (25th, 75th: 17.9, 29.6). These education data are consistent with national statistics. 28 Table 2 shows the association of county-level SES variables from area resource files after adjusting for (1) SES variables and patient characteristics and (2) SES variables, patient characteristics, and hospital characteristics. After adjusting for SES variables and patient and hospital characteristics, median household income per $5000 increase was modestly but significantly associated with a lower odds of 30-day mortality (odds ratio, 0.97; 95% confidence interval, 0.95-1.00; P=0.032). With the same multivariable adjustment, the proportion of people with at least a high school diploma was associated with lower odds of 30-day rehospitalization (odds ratio, 0.95; 95% confidence interval, 0.91-0.99). When adjusting only for race and ethnicity, Hispanic ethnicity and black race are significantly associated with lower 30-day mortality and higher 30-day admission ( Table 3 ). After adjustment for SES environment, Hispanic ethnicity and black race remained significantly associated with 30-day mortality (Hispanic ethnicity: odds ratio, 0.70; 95% confidence interval, 0.58-0.83 and black race: odds ratio, 0.57; 95% confidence interval, 0.50-0.65), but not with 30-day rehospitalization. Table 4 compares the discriminatory capabilities of models that adjust for SES, patient, and hospital characteristics. There was no perceptible improvement in discrimination beyond patient characteristics for SES or hospital characteristics for either 30-day end point (C-index for all 30-day mortality models, 0.74; C-index for all 30-day rehospitalization models, 0.62). Model calibration is shown in the plots of observed versus predicted outcomes defined by deciles (Figure in the Data Supplement). Hospital rankings by 30-day mortality and 30-day rehospitalization were highly correlated among all models, but particularly among models that adjusted for patient characteristics (Table 5 ).
Discussion
Public reporting and financial penalties have made hospitals accountable for 30-day outcomes in select conditions: HF, acute myocardial infarction, and pneumonia. Public, and possibly financial, accountability is extending to hospital-wide rehospitalization rates. 29 As a result, there is an increasing focus on the methodology used to risk-adjust for outcomes measures like hospital rehospitalization rates. To date, risk adjustment accounts for the clinical characteristics of patients, but not the SES environment in which they live. Prior studies have demonstrated the relationship of the SES environment with both patient morbidity and mortality. Moreover, the SES environment is associated with a hospital's financial and clinical resources. Hospitals that care for disadvantaged populations often have limited resources and, ultimately, higher rehospitalization rates for HF. 30 Without accounting for the SES environment, financial penalties may disproportionately affect providers who serve disadvantaged populations, which ultimately will widen disparities in care.
In this analysis of 48 338 patients from 197 hospitals in GWTG-HF linked with the CMS database and census data, we found that a higher community median household income was associated with a patient having a lower odds of 30-day mortality. We also found that the proportion of people with at least a high school diploma within a community was associated with lower odds of 30-day rehospitalization. Furthermore, county-level SES data adjusted away the association of black race or Hispanic ethnicity with 30-day rehospitalization. However, census-level data did not improve risk adjustment nor did it change hospital rankings for 30-day rehospitalization or mortality based on patientlevel characteristics alone.
Clinical outcomes such as rehospitalization and mortality are ideal for accountability applications such as public reporting and pay-for-performance, but it is often difficult to place full accountability on 1 institution (eg, a hospital). In an effort to account for the differences in patient populations, outcomes are adjusted for patient comorbidities and severity of illness. Current models do not account for race or SES, although these characteristics are shown in our analysis, as well as prior studies, to be associated with early postdischarge outcomes in HF. For example, Nagasako et al 31 found that including community-level SES characteristics such as county median income greatly reduced variation in hospital risk-standardized readmission rates for patients with HF in Missouri. Among New York City hospitals, Blum et al 32 demonstrated that SES was associated with 30-day readmission rates for patients with HF, but did not improve the discriminatory capacity of risk adjustment models. To our knowledge, our study is among the first to examine the impact of SES data on risk adjustment models in a large data set representative of patients and hospitals across the United States. Similar to previous studies, 23, 33, 34 we found that black race and Hispanic ethnicity are associated with lower rates of postdischarge mortality and higher rates of readmission for patients with HF. Furthermore, we found that the association of black race and Hispanic ethnicity with lower 30-day mortality remained after adjusting for the SES environment. Despite disparities in care, this relationship has also been identified in other conditions including stroke. 35 The reasons for differences in outcome according to race/ethnicity are varied and include factors at the hospital-level (eg, quality of care) and patient-level (eg, preferences of care). Our findings are also concordant with prior studies, which suggest that an individual's health is related to the environment in which he or she lives. Using data from the Atherosclerosis Risk in Communities Study, Diez-Roux et al 19, 21 showed that living in a disadvantaged neighborhood was associated with an increased incidence of coronary heart disease, as well as an increased prevalence of risk factors, even after adjusting for personal income, education, and occupation. Linking data from the National Longitudinal Mortality Study to census tract information, Anderson et al 11 found that up to one-third of the mortality associated with residence in low-income areas was independent of personal income level. Yen and Kaplan 13 found that mortality risks were significantly higher in neighborhoods with a low social environment, even after accounting for individual income level, education, race/ethnicity, perceived health status, smoking status, body mass index, and alcohol consumption. Among patients hospitalized for HF, a single-center study of a large urban hospital found that community-level factors such as income level for zip code of residence can improve prediction of 30-day rehospitalization. 36 The inter-relatedness between SES characteristics of the communities that hospitals serve and patient race/ ethnicity has not been fully explored. Our findings suggest that SES at least partially accounts for the relationship of race and ethnicity with early postdischarge outcomes for patients with HF. Heterogeneity within counties likely dilutes the discriminatory capacity of the SES variables used in this analysis. More granular data will elucidate whether factors unrelated to systems of care, including race/ethnicity and SES, would improve risk adjustment and efforts to incentivize more equitable care. Geographic health information systems, which integrate clinical data with census data and other communitylevel information, can enable a more precise evaluation of the distribution of SES characteristics within communities and their relation to clinical outcomes. Such systems have been used to identify local predictors of emergency department use and are scalable. 37 Integrating geospatial data with nationwide quality improvement initiatives could not only improve risk adjustment and predictive modeling for clinical outcomes but also enhance population health management efforts.
Limitations
Our study has several limitations. First, the study population comprised CMS fee-for-service beneficiaries enrolled in GWTG-HF and might not be clinically representative of all patients hospitalized with HF. The outcomes are likely conservative given the voluntary participation of hospitals in this quality improvement registry; however, analyses of a similar clinical registry called the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Registry indicated that enrolled patients were reasonably representative of the broader CMS population with HF. 38 Second, traditional variables such as median household income and median home value are poorer measures of SES in this older population, many of whom may be retired. As a result, the weak association observed with these SES variables may be further diluted. Nevertheless, it is important to pursue the objective of our article (ie, to determine the use of SES in risk-adjusting outcomes for CMS beneficiaries with HF), given the financial implications of risk-adjusted readmission and mortality rates for this specific population. Third, a stronger relationship between county-level SES data and outcomes may have emerged with longer term follow-up and with the use of more granular SES data. Fourth, the data in this study are dependent on the quality of medical record documentation and chart abstraction. Fifth, study results can be influenced by differences in assessment, treatment, and documentation patterns at participating hospitals. Finally, residual confounding (measured and unmeasured) may account for some or all of these observations.
Conclusions
Census-level SES data are modestly associated with 30-day outcomes for CMS beneficiaries hospitalized with HF, but do not improve risk adjustment models based on patient characteristics alone. SES data at a more detailed level may improve understanding of the relationship between SES and 30-day outcomes in HF.
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